gentaur logogentaur logo
x

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein
SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

1328.00 €

1328.00 €
In Stock
quantity
product details

Catalog number: 223 - 97-085

Product Category: Business & Industrial > Science & Laboratory

Supplier:

ProSciGentaur

Size: 0.1 mg

Related Products

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

20-204

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

1232.55 €

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

20-229

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

1232.55 €

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

92-728

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

1681.14 €

Nucleocapsid protein is a most abundant protein of coronavirus. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. While screening for ADP-ribosylated proteins during coronavirus (CoV) infection, we identified as the viral nucleocapsid (N) protein. Novel post-translation modification of the CoV N protein that may play a regulatory role for this important structural protein. The array of diverse functional activities accommodated in the hantaviral N protein goes far beyond to be a static structural protein and makes it an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.